Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Unit Feb 2023 Infection Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study Autoren Pilgram L et al. Feb 2023 Commun Biol Genome-scale model of Pseudomonas aeruginosa metabolism unveils virulence and drug potentiation Autoren Dahal S et al. Feb 2023 Science Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication Autoren Tsukamoto Y et al. Feb 2023 JCI Insight Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness Autoren Feng A et al. Feb 2023 Nat Commun Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria Autoren Collias D et al. Feb 2023 Z Evid Fortbild Qual Gesundhwes [Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic] Autoren Tscharntke L et al. Feb 2023 Hepatology EGF receptor modulates HEV entry in human hepatocytes Autoren Schrader JA et al. Feb 2023 Front Immunol Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2 Autoren Monzon-Posadas WO et al. Feb 2023 PLoS Pathog Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses Autoren Scheibner D et al. Feb 2023 J Hosp Infect Survival and inactivation of hepatitis E virus on inanimate surfaces Autoren Wißmann JE et al. Feb 2023 Front Immunol Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability? Autoren Horvath A et al. Feb 2023 Hepatology Hepatitis delta: epidemiology to recent advances in therapeutic agents Autoren Abdul Majeed N et al. Feb 2023 Nat Commun Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe meningoencephalomyelitis in domestic cats Autoren Matiasek K et al. Feb 2023 PLoS One Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study Autoren Gobena D et al. Feb 2023 EMBO J Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement Autoren Zhao F et al. Feb 2023 Lancet Infect Dis Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis Autoren Willems RPJ et al. Feb 2023 Lancet Infect Dis Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits? Autoren Hoehl S Ciesek S Feb 2023 J Med Virol RSV-CLASS -Clinical Assessment Severity Score: An easy-to-use clinical disease severity score for respiratory syncytial virus infection in hospitalized children Autoren Gsenger J et al. Feb 2023 Nat Commun SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection Autoren Pušnik J et al. Feb 2023 J Infect Pretomanid-Resistant Tuberculosis Autoren Koehler N et al. Feb 2023 Brain Connect European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19 Autoren Crook H et al. Feb 2023 J Control Release Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models Autoren Dal NJK et al. Jan 2023 Front Immunol Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity Autoren Henze L et al. Jan 2023 ACS Infect Dis Synthesis and Characterization of DOTAM-Based Sideromycins for Bacterial Imaging and Antimicrobial Therapy Autoren Peukert C et al. Jan 2023 Open forum infect dis Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals Autoren Doua J et al. Pagination Previous page ‹‹ Seite 85 Seite 86 Seite 87 Seite 88 Current page 89 Seite 90 Seite 91 Seite 92 Seite 93 Seite 85 Seite 86 Seite 87 Seite 88 Seite 89 Seite 90 Seite 91 Seite 92 Seite 93 Next page ››
Feb 2023 Infection Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study Autoren Pilgram L et al.
Feb 2023 Commun Biol Genome-scale model of Pseudomonas aeruginosa metabolism unveils virulence and drug potentiation Autoren Dahal S et al.
Feb 2023 Science Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication Autoren Tsukamoto Y et al.
Feb 2023 JCI Insight Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness Autoren Feng A et al.
Feb 2023 Nat Commun Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria Autoren Collias D et al.
Feb 2023 Z Evid Fortbild Qual Gesundhwes [Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic] Autoren Tscharntke L et al.
Feb 2023 Front Immunol Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2 Autoren Monzon-Posadas WO et al.
Feb 2023 PLoS Pathog Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses Autoren Scheibner D et al.
Feb 2023 J Hosp Infect Survival and inactivation of hepatitis E virus on inanimate surfaces Autoren Wißmann JE et al.
Feb 2023 Front Immunol Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability? Autoren Horvath A et al.
Feb 2023 Hepatology Hepatitis delta: epidemiology to recent advances in therapeutic agents Autoren Abdul Majeed N et al.
Feb 2023 Nat Commun Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe meningoencephalomyelitis in domestic cats Autoren Matiasek K et al.
Feb 2023 PLoS One Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study Autoren Gobena D et al.
Feb 2023 EMBO J Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement Autoren Zhao F et al.
Feb 2023 Lancet Infect Dis Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis Autoren Willems RPJ et al.
Feb 2023 Lancet Infect Dis Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits? Autoren Hoehl S Ciesek S
Feb 2023 J Med Virol RSV-CLASS -Clinical Assessment Severity Score: An easy-to-use clinical disease severity score for respiratory syncytial virus infection in hospitalized children Autoren Gsenger J et al.
Feb 2023 Nat Commun SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection Autoren Pušnik J et al.
Feb 2023 Brain Connect European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19 Autoren Crook H et al.
Feb 2023 J Control Release Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models Autoren Dal NJK et al.
Jan 2023 Front Immunol Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity Autoren Henze L et al.
Jan 2023 ACS Infect Dis Synthesis and Characterization of DOTAM-Based Sideromycins for Bacterial Imaging and Antimicrobial Therapy Autoren Peukert C et al.
Jan 2023 Open forum infect dis Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals Autoren Doua J et al.
